title: Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
abstract: OBJECTIVE
  To evaluate Ped/pea-15 (phosphoprotein enriched in diabetes) expression in polycystic ovary syndrome (PCOS) women.
  
  
  METHODS
  Thirty PCOS women were studied and compared with other 30 age- and body mass index (BMI)-matched women, considered as the control group. Both patients and controls were divided according to BMI. All subjects underwent endocrine and metabolic investigation and Ped/pea-15 expression was evaluated by western blot analysis. Insulin resistance was assessed by HOMA model and insulin sensitivity index (ISI) composite.
  
  
  RESULTS
  Insulin resistance, evaluated by HOMA-R and ISI composite, was significantly higher in PCOS women and in obese controls than in normal weight controls. Ped/pea-15 expression (%) was higher in PCOS women than in controls (440.4 +/- 220.7 vs. 163.0 +/- 45.5; P < 0.001; range 145.5-987% and 97-281%, respectively), and was positively correlated with insulin, BMI, total testosterone, HOMA index, and family history (P < 0.001). In patients with PCOS univariate analysis of variance showed no effect of BMI variation (P = 0.13) on Ped/pea-15 expression levels. On multiple linear regression analysis, the major determinants of Ped/pea-15 overexpression were family history, insulin, and PCOS status independent of BMI.
  
  
  CONCLUSIONS
  These preliminary data (1) highlight the overexpression of Ped/pea-15 in PCOS compared to normal controls, independent of obesity; (2) suggest that Ped/pea-15 overexpression might be an early component of the metabolic syndrome in PCOS; and (3) support the hypothesis that Ped/pea-15 represents a possible useful tool to assess the presence of a genetic condition associated with insulin resistance in PCOS.
authors.affiliation: Department of Molecular and Clinical Endocrinology and Oncology, University Federico II, Naples, Italy. sisavast@unina.it
authors.forename: Silvia
authors.initials: S
authors.lastname: Savastano
authors.forename: Francesco
authors.initials: F
authors.lastname: Orio
authors.forename: Stefano
authors.initials: S
authors.lastname: Palomba
authors.forename: Teresa
authors.initials: T
authors.lastname: Cascella
authors.forename: Francesco
authors.initials: F
authors.lastname: Manguso
authors.forename: Gelsy Arianna
authors.initials: GA
authors.lastname: Lupoli
authors.forename: Pietro
authors.initials: P
authors.lastname: Formisano
authors.forename: Gaetano
authors.initials: G
authors.lastname: Lombardi
authors.forename: Annamaria
authors.initials: A
authors.lastname: Colao
authors.forename: Francesco
authors.initials: F
authors.lastname: Beguinot
authors.forename: Rossella
authors.initials: R
authors.lastname: Valentino
mesh_terms: D000328:Adult; D051017:Apoptosis Regulatory Proteins; D015415:Biomarkers / Q000097:blood; D015153:Blotting, Western / Q000379:methods; D015992:Body Mass Index; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis*; D015999:Multivariate Analysis; D009765:Obesity / Q000097:blood; D010750:Phosphoproteins / Q000032:analysis*; D011085:Polycystic Ovary Syndrome / Q000097:blood*; D013739:Testosterone / Q000097:blood
chemical_list: D051017:Apoptosis Regulatory Proteins; D015415:Biomarkers; D007328:Insulin; D047908:Intracellular Signaling Peptides and Proteins; C092039:PEA15 protein, human; D010750:Phosphoproteins; D013739:Testosterone